{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:40:25Z","timestamp":1761100825014},"reference-count":59,"publisher":"Wiley","issue":"3-4","license":[{"start":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T00:00:00Z","timestamp":1134345600000},"content-version":"vor","delay-in-days":102,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chromosomal aberrations are the most important prognostic factors in haematological malignancies. Detection of certain genetic changes leads to risk adapted strategies in leukaemia therapy. In multiple myeloma the importance of genetic alterations and their prognostic impact is of growing interest. Several therapeutic approaches seem to be uneffective for patients harbouring certain chromosomal abnormalities.<\/jats:p><jats:p>Although the yield of metaphases due to a low proliferation rate is considerably lower in plasma cell dyscrasias, a number of chromosomal changes with prognostic implications have been identified in the past years, particularly due to the introduction of new techniques.<\/jats:p><jats:p>This article gives a short survey of the most important genetic alterations and their prognostic influence on the outcome of patients with plasma cell malignancies known to date. Copyright \u00a9 2005 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hon.757","type":"journal-article","created":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T10:47:19Z","timestamp":1134384439000},"page":"102-107","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance"],"prefix":"10.1002","volume":"23","author":[{"given":"Georgia","family":"Schilling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Dierlamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter K","family":"Hossfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,12]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00464.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(99)00009-6"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(93)90071-M"},{"issue":"12","key":"e_1_2_1_5_2","first-page":"2119","article-title":"Correlations between karyotype and cytologic findings in multiple myeloma","volume":"9","author":"Weh HJ","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.0.CO;2-X"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)90092-2"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2443061.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00657.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401041"},{"issue":"12","key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V95.12.4008","article-title":"Results of high\u2010dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities","volume":"95","author":"Desikan R","year":"2000","journal-title":"Blood"},{"issue":"8","key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V91.8.3007.3007_3007_3010","article-title":"Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization","volume":"91","author":"Cigudosa JC","year":"1998","journal-title":"Blood"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02546.x"},{"issue":"5","key":"e_1_2_1_15_2","first-page":"1743","article-title":"Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma","volume":"92","author":"Rao PH","year":"1998","journal-title":"Blood"},{"issue":"2","key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","article-title":"The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis","volume":"66","author":"Dewald GW","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)00284-I"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.4.804"},{"issue":"8","key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1182\/blood.V92.8.2997","article-title":"Detection of nonrandom chromosomal changes in multiple myeloma by comparative genomic hybridization","volume":"92","author":"Avet\u2010Loiseau H","year":"1998","journal-title":"Blood"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03757.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4435"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.2185"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02248.x"},{"issue":"3","key":"e_1_2_1_24_2","first-page":"715","article-title":"Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study","volume":"62","author":"Fonseca R","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","article-title":"High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH","volume":"96","author":"Shaughnessy J","year":"2000","journal-title":"Blood"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01615.x"},{"issue":"12","key":"e_1_2_1_27_2","first-page":"2539","article-title":"p53 and RAS gene mutations in multiple myeloma","volume":"7","author":"Portier M","year":"1992","journal-title":"Oncogene"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08253.x"},{"issue":"1","key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V81.1.128.128","article-title":"p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy","volume":"81","author":"Neri A","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_30_2","first-page":"680a","article-title":"High incidence of p53 deletion in plasma cell leukemia (PCL), and multiple myeloma (MM) with leukemic transformation (MMLT)","volume":"102","author":"Santana\u2010Davila R","year":"2003","journal-title":"Blood"},{"issue":"3","key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V92.3.802","article-title":"Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional\u2010dose chemotherapy","volume":"92","author":"Drach J","year":"1998","journal-title":"Blood"},{"key":"e_1_2_1_32_2","unstructured":"DierlammJ SchillingG S\u00fc\u00dfmilchS et al.Interphase FISH analysis of deletions of tumor suppressor genes and aneuploidies in multiple myeloma shows significant clinical correlations. 43rd Annual Meeting of the American Society of Hematology December2001."},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05199.x"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1411"},{"issue":"6","key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580","article-title":"p53 gene deletion predicts for poor survival and non\u2010response to therapy with purine analogs in chronic B\u2010cell leukemias","volume":"85","author":"D\u00f6hner H","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.13931"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.2.526"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05050.x"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.14.11.7581"},{"issue":"10","key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood.V90.10.4062","article-title":"A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth\u2010factor receptor 3 gene","volume":"90","author":"Richelda R","year":"1997","journal-title":"Blood"},{"issue":"2","key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V94.2.724","article-title":"Detection of t(4;14) (p16.3;q32) chromosomal translocation in multiple myeloma by double\u2010color fluorescent in situ hybridization","volume":"94","author":"Finelli P","year":"1999","journal-title":"Blood"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.9.3025"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1675"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0749"},{"key":"e_1_2_1_45_2","unstructured":"Dewaldet al.1985."},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1159\/000204010"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674"},{"issue":"8","key":"e_1_2_1_48_2","first-page":"2691","article-title":"Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)","volume":"95","author":"Janssen JW","year":"2000","journal-title":"Blood"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(97)00469-X"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00700.x"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3017"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.822"},{"issue":"9","key":"e_1_2_1_53_2","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.V90.9.3682","article-title":"Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition","volume":"90","author":"Zandecki M","year":"1997","journal-title":"Blood"},{"issue":"17","key":"e_1_2_1_54_2","first-page":"3854","article-title":"Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization","volume":"55","author":"Drach J","year":"1995","journal-title":"Cancer Res"},{"issue":"18","key":"e_1_2_1_55_2","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome","volume":"59","author":"Avet\u2010Loiseau H","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401909"},{"issue":"8","key":"e_1_2_1_57_2","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","article-title":"Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome","volume":"94","author":"Avet\u2010Loiseau H","year":"1999","journal-title":"Blood"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03651.x"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01124.x"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.757","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T16:44:28Z","timestamp":1693500268000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":59,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1002\/hon.757"],"URL":"https:\/\/doi.org\/10.1002\/hon.757","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}